Search research articles
Contact Us
Filters
Showing results (141-150 of 182) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor
A Craig Lockhart, Rod D Braun, Daohai Yu, et al.
Cancer Chemotherapy and Pharmacology
|
May 29, 2012
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
Gordana Vlahovic, Kellen L Meadows, Hope E Uronis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2006
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results
Brian G Czito, Christopher G Willett, Johanna C Bendell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer
Johanna C Bendell, Michael S Gordon, Herbert I Hurwitz, et al.
Annals of Surgical Oncology
|
April 14, 2005
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer
Rebekah R White, H Bill Xie, Marcia R Gottfried, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer
Axel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
Annals of Surgical Oncology
|
January 5, 2002
Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas
R R White, H I Hurwitz, M A Morse, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2019
A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)
Jeffrey Melson Clarke, Gerard C Blobe, John H Strickler, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
June 28, 2002
Staging of pancreatic cancer before and after neoadjuvant chemoradiation
R R White, E K Paulson, K S Freed, et al.
Nucleic Acids Research
|
November 29, 2019
CDD/SPARCLE: the conserved domain database in 2020
Shennan Lu, Jiyao Wang, Farideh Chitsaz, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 182) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor
A Craig Lockhart, Rod D Braun, Daohai Yu, et al.
Cancer Chemotherapy and Pharmacology
|
May 29, 2012
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
Gordana Vlahovic, Kellen L Meadows, Hope E Uronis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2006
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results
Brian G Czito, Christopher G Willett, Johanna C Bendell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer
Johanna C Bendell, Michael S Gordon, Herbert I Hurwitz, et al.
Annals of Surgical Oncology
|
April 14, 2005
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer
Rebekah R White, H Bill Xie, Marcia R Gottfried, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer
Axel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
Annals of Surgical Oncology
|
January 5, 2002
Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas
R R White, H I Hurwitz, M A Morse, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2019
A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)
Jeffrey Melson Clarke, Gerard C Blobe, John H Strickler, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
June 28, 2002
Staging of pancreatic cancer before and after neoadjuvant chemoradiation
R R White, E K Paulson, K S Freed, et al.
Nucleic Acids Research
|
November 29, 2019
CDD/SPARCLE: the conserved domain database in 2020
Shennan Lu, Jiyao Wang, Farideh Chitsaz, et al.
Page
of 19